Among these lncRNAs, HAND2‐AS1 has been experimentally validated as a suppressor in multiple cancers, like esophagus squamous cell cancer, nonsmall cell lung cancer, colorectal cancer, osteosarcoma, and endometrioid endometrial cancer.29, 30, 31, 32, 33. This evidence concerns the gene HAND2 and colorectal cancer.